A Multidisciplinary Approach to the Diagnosis and Optimal Management of Primary Immunodeficiency: The Latest Evidence and Best Practices

CMEO Live and On Demand

Premiere Date: Wednesday, March 4, 2020
Live Broadcast: 12:00–1:30 p.m. ET
"After the Show" live Q&A webcast: 1:02 p.m.–1:30 p.m. ET
Taped Re-Air: 4:00–5:30 p.m. ET

This activity offers CE credit for:

  1. Physicians (CME)
  2. Nurses (CNE)
  3. Pharmacists (ACPE)
  4. ABIM (MOC)
  5. Other


All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date: Thursday, March 4, 2021

Register for Activity

Faculty


Mark Ballow, MD Mark Ballow, MD (Moderator)
Professor, Department of Pediatrics
University of South Florida, Morsani College of Medicine
Division of Allergy & Immunology
Johns Hopkins All Children's Hospital
St. Petersburg, FL

Kristin Epland, MSN, FNP-C Kristin Epland, MSN, FNP-C 
Family Nurse Practitioner
Midwest Immunology Clinic
Plymough, MN

Niraj C. Patel, MD, MS Niraj C. Patel, MD, MS 
Chief, Pediatric Infectious Disease and Immunology
Director, Charlotte Immunodeficiency Center
Adjunct Associate Professor, University of North Carolina
Levine Children's Hospital, Atrium Health
Charlotte, NC

Statement of Need

Primary immunodeficiency disorders (PIDs) are a group of genetic disorders that affect development and function in the immune system. PIDs can leave patients vulnerable to frequent, severe, and unusual infections, and are associated with significant morbidity; patients with PIDs are twice as likely to be hospitalized and have significantly longer hospital stays.

Timely diagnosis and early treatment interventions are critically important to mitigate the disease and economic burden of PID, but the management of PID can be challenging for clinicians due to its complexity. Human immune globulin (Ig) therapy has significantly improved life expectancy and quality of life (QoL) for patients with PID; however, selecting a therapeutic product can be a complex choice, as it requires a thorough understanding of the classification of PIDs and the appropriate matching of a personalized treatment based on patient-specific factors.

This CME Outfitters Live and On Demand webcast is a case-based activity featuring expert faculty addressing the diagnosis and management of PIDs, as well as strategies for raising PID awareness and education.

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Identify signs and symptoms of primary immunodeficiency to decrease diagnostic delays.
  • Implement evidence-based treatment strategies to manage PID.
  • Educate and inform patients about PID to reduce morbidity and improve quality of life (QoL).

The following learning objectives pertain only to those requesting CNE or CPE credit:

  • Identify signs and symptoms of primary immunodeficiency to decrease diagnostic delays.
  • Discuss evidence-based treatment strategies to manage PID.
  • Describe ways to educate and inform patients about PID to reduce morbidity and improve quality of life (QoL).

Financial Support

Supported by educational grants from CSL Behring LLC, Grifols, and Pfizer Inc.

Target Audience

Primary care physicians, pediatricians, specialists, infusion nurses, pharmacists, nurse practitioners, and physician assistants.

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Outfitters, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours.

Note to Nurse Practitioners: Nurse Practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

CPE Credit (Pharmacists):
ACPE CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs) Universal Activity Number:
Live: 0376-0000-20-006-L01-P
Enduring: 0376-0000-20-006-H01-P

Type: Knowledge-based

ABIM/MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Learning Formats
Live activity
Enduring material

ABP MOC Credit:
Successful completion of this CME activity, which includes participation in the activity and individual assessment of and feedback to the learner, enables the learner to earn up to 1.5 MOC points in the American Board of Pediatrics' (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

MIPS Improvement Activity: This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the Accreditation Council for Continuing Medical Education.

Royal College MOC:Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners in the Royal College MOC Program may record completion of accredited activities registered under the ACCME's "CME in Support of MOC" program in Section 3 of the Royal College's MOC Program.

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit https://www.cmeoutfitters.com/privacy-and-confidentiality-policy

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Ballow reports that he is on the advisory committee for CSL Behring; and Takeda Pharmaceuticals U.S.A., Inc. He is a consultant for Grifols. He is on the speakers bureau for CSL Behring and Takeda Pharmaceuticals U.S.A., Inc.

Ms. Epland reports that she serves on the advisory committee for IDF Nurse Advisory Committee; Pharming Group NV and Takeda Pharmaceuticals, Inc. U.S.A. (Immunoglobulin Nurse Advisor). She serves as a consultant for the Takeda Pharmaceuticals, Inc. U.S.A speaker program.

Dr. Patel reports that he received research support from CSL Behring and Takeda. He is on the advisory committee for Baxalta Inc. and Horizon Therapeutics. he is on the speakers bureau for CSL Behring; Horizon Therapeutics and Takeda Pharmaceuticals U.S.A., Inc.

Poshala Tish Aluwihare, PhD (planning committee) has no disclosures to report.

Evan Luberger (planning committee) has no disclosures to report.

Jan Perez (planning committee) has no disclosures to report.

Sharon Tordoff (planning committee) has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).


This document was last modified on:

TV-110-030420-90